162 related articles for article (PubMed ID: 27531258)
1. Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.
Zhang R; Wang L; Garrett SH; Sens DA; Dunlevy JR; Zhou XD; Somji S
Exp Toxicol Pathol; 2016 Oct; 68(9):479-491. PubMed ID: 27531258
[TBL] [Abstract][Full Text] [Related]
2. The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers.
Hoggarth ZE; Osowski DB; Freeberg BA; Garrett SH; Sens DA; Sens MA; Zhou XD; Zhang KK; Somji S
PLoS One; 2018; 13(12):e0207877. PubMed ID: 30550540
[TBL] [Abstract][Full Text] [Related]
3. Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a.
Somji S; Bathula CS; Zhou XD; Sens MA; Sens DA; Garrett SH
Environ Health Perspect; 2008 Apr; 116(4):434-40. PubMed ID: 18414623
[TBL] [Abstract][Full Text] [Related]
4. The expression of keratin 6 is regulated by the activation of the ERK1/2 pathway in arsenite transformed human urothelial cells.
Slusser-Nore A; Garrett SH; Zhou XD; Sens DA; Sens MA; Somji S
Toxicol Appl Pharmacol; 2017 Sep; 331():41-53. PubMed ID: 28501331
[TBL] [Abstract][Full Text] [Related]
5. Enrichment of genes associated with squamous differentiation in cancer initiating cells isolated from urothelial cells transformed by the environmental toxicant arsenite.
Hoggarth ZE; Osowski DB; Slusser-Nore A; Shrestha S; Pathak P; Solseng T; Garrett SH; Patel DH; Savage E; Sens DA; Somji S
Toxicol Appl Pharmacol; 2019 Jul; 374():41-52. PubMed ID: 31047981
[TBL] [Abstract][Full Text] [Related]
6. Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa).
Somji S; Zhou XD; Mehus A; Sens MA; Garrett SH; Lutz KL; Dunlevy JR; Zheng Y; Sens DA
Chem Res Toxicol; 2010 Feb; 23(2):348-56. PubMed ID: 19921857
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer.
Zhou XD; Sens DA; Sens MA; Namburi VB; Singh RK; Garrett SH; Somji S
Toxicol Sci; 2006 Jun; 91(2):467-75. PubMed ID: 16565513
[TBL] [Abstract][Full Text] [Related]
8. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells.
Sens DA; Park S; Gurel V; Sens MA; Garrett SH; Somji S
Toxicol Sci; 2004 May; 79(1):56-63. PubMed ID: 14976345
[TBL] [Abstract][Full Text] [Related]
9. Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As(+3)- and Cd (+2)-induced bladder cancer : keratin 6, 7, 16, 17, and 19 in bladder cancer.
Somji S; Cao L; Mehus A; Zhou XD; Sens MA; Dunlevy JR; Garrett SH; Zheng Y; Larson JL; Sens DA
Cell Biol Toxicol; 2011 Dec; 27(6):381-96. PubMed ID: 21927821
[TBL] [Abstract][Full Text] [Related]
10. SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite.
Larson J; Yasmin T; Sens DA; Zhou XD; Sens MA; Garrett SH; Dunlevy JR; Cao L; Somji S
Toxicol Lett; 2010 Nov; 199(2):166-72. PubMed ID: 20837119
[TBL] [Abstract][Full Text] [Related]
11. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
Cao L; Zhou XD; Sens MA; Garrett SH; Zheng Y; Dunlevy JR; Sens DA; Somji S
J Appl Toxicol; 2010 Jul; 30(5):416-30. PubMed ID: 20186695
[TBL] [Abstract][Full Text] [Related]
12. Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3- and Cd+2-Transformed Human Urothelial (UROtsa) Cell Lines.
Sandquist EJ; Somji S; Dunlevy JR; Garrett SH; Zhou XD; Slusser-Nore A; Sens DA
PLoS One; 2016; 11(5):e0156310. PubMed ID: 27224422
[TBL] [Abstract][Full Text] [Related]
13. Increased neuron specific enolase expression by urothelial cells exposed to or malignantly transformed by exposure to Cd²⁺ or As³⁺.
Soh M; Dunlevy JR; Garrett SH; Allen C; Sens DA; Zhou XD; Sens MA; Somji S
Toxicol Lett; 2012 Jul; 212(1):66-74. PubMed ID: 22613180
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of metallothionein isoform 3 protein in tumor heterotransplants derived from As+3- and Cd+2-transformed human urothelial cells.
Zhou XD; Sens MA; Garrett SH; Somji S; Park S; Gurel V; Sens DA
Toxicol Sci; 2006 Oct; 93(2):322-30. PubMed ID: 16854967
[TBL] [Abstract][Full Text] [Related]
15. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
Eblin KE; Bredfeldt TG; Gandolfi AJ
Toxicology; 2008 Jun; 248(2-3):67-76. PubMed ID: 18456381
[TBL] [Abstract][Full Text] [Related]
16. SPARC Expression Is Selectively Suppressed in Tumor Initiating Urospheres Isolated from As+3- and Cd+2-Transformed Human Urothelial Cells (UROtsa) Stably Transfected with SPARC.
Slusser-Nore A; Larson-Casey JL; Zhang R; Zhou XD; Somji S; Garrett SH; Sens DA; Dunlevy JR
PLoS One; 2016; 11(1):e0147362. PubMed ID: 26783756
[TBL] [Abstract][Full Text] [Related]
17. Urothelial cells malignantly transformed by exposure to cadmium (Cd(+2)) and arsenite (As(+3)) have increased resistance to Cd(+2) and As(+3)-induced cell death.
Somji S; Zhou XD; Garrett SH; Sens MA; Sens DA
Toxicol Sci; 2006 Dec; 94(2):293-301. PubMed ID: 16980690
[TBL] [Abstract][Full Text] [Related]
18. Kindlin-2 expression in arsenite- and cadmium-transformed bladder cancer cell lines and in archival specimens of human bladder cancer.
Talaat S; Somji S; Toni C; Garrett SH; Zhou XD; Sens MA; Sens DA
Urology; 2011 Jun; 77(6):1507.e1-7. PubMed ID: 21624607
[TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
[TBL] [Abstract][Full Text] [Related]
20. Connexin 26 is abnormally expressed in bladder cancer.
Gee J; Tanaka M; Grossman HB
J Urol; 2003 Mar; 169(3):1135-7. PubMed ID: 12576868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
